v3.26.3
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net loss $ (73,379,021) $ (46,762,625)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 5,006,128 5,044,937
Accretion of financing costs 307,428 3,776,177
Amortization of right-of-use asset 122,548 113,589
Credit loss on receivable pursuant to share purchase agreement (Tysadco) 1,415,803
Write-down of inventory to net realizable value 887,344 2,919,638
Other non-cash expenses 1,298,812
Stock-based compensation 46,480,593 14,653,807
Change in fair value of derivative liability (705,184)
Change in fair value of conversion option (138,060)
Change in fair value of liability-classified equity-linked contracts (737,040)
Loss on debt extinguishment 675,648
Loss on private placement 567,161
Changes in operating assets and liabilities:    
Accounts receivable (4,153,326) (2,571,104)
Inventory (1,063,960) (3,173,465)
Grant receivables 26,467 (52,716)
Prepaid expenses and other 588,114 (1,071,849)
Other receivables (561,940)
Accounts payable and accrued liabilities 369,121 (2,759,955)
Operating lease liability (115,863) (115,920)
Net Cash Used in Operating Activities (24,187,555) (28,921,158)
Cash Flows From Investing Activities:    
Acquisition of property and equipment (12,151,190) (2,548,476)
Purchase of mining properties (1,426,678)
Net Cash Used in Investing Activities (13,577,868) (2,548,476)
Cash Flows From Financing Activities:    
Proceeds from exercise of share purchase warrants 9,983,020 37,500
Proceeds from employee stock purchase plan 708,021 367,110
Proceeds from issuance of common shares through At-The-Market Offering 65,806,854 18,579,975
Payment of issuance costs of common shares through At-The-Market Offering (887,302) (270,100)
Proceeds from subscription agreements 1,900,000
Proceeds from registered direct offerings 15,000,000
Payment of issuance costs, registered direct offerings (1,089,000)
Principal paid on notes payable (7,483,333)
Proceeds from notes payable, net of issuance costs 9,900,000
Net Cash Provided by Financing Activities 75,610,593 36,942,152
Increase in Cash, Cash Equivalents and Restricted Cash 37,845,170 5,472,518
Cash, Cash Equivalents and Restricted Cash – Beginning of Period 12,474,304 7,001,786
Cash, Cash Equivalents and Restricted Cash – End of Period $ 50,319,474 $ 12,474,304